References
Bandilla, K.; Gross, D.; Gross, W.; Herrlinger, J.-D.; Kriegel, W.; Müller, W.; Siegmeth, W.; Tausch, G.; Thumb, N. and Wagenhäuser, F.J.: Oral gold therapy with auranofin (SK&F 39162). Journal of Rheumatology 9 (Suppl. 8): 154–159 (1982).
Barraclough, D.; Brook, A.; Brooks, P.; Boyden, K.; Thomas, D. and Tymms, K.: Auranofin, gold sodium thiomalate, and d-penicillamine in rheumatoid arthritis: A progress report. Journal of Rheumatology 9 (Suppl. 8): 197–200 (1982).
Bernhard, G.C.: Auranofin treatment for adult rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 149–153 (1982).
Blodgett Jr, R.C.: Auranofin symposium–an epilogue. Journal of Rheumatology 9 (Suppl. 8): 207–208 (1982).
Bunch, T.W. and O’Duffy, J.D.: Disease-modifying drugs for progressive rheumatoid arthritis. Mayo Clinic Proceedings 55: 161–179 (1980).
Bunch, T.W.; O’Duffy, J.D.; Tompkins, R.B. and O’Fallon, W.M.: Controlled trial of hydroxychloroquine and penicillamine singly and in combination in treatment of rheumatoid arthritis. Arthritis and Rheumatism (In press, 1984).
Champion, G.D.; Bieri, D.; Browne, C.D.; Day, R.O.; Graham, G.G.; Haavisto, T.M.; Sambrook, P.N. and Vallance, J.B.: Auranofin in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 137–145 (1982).
Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of cyclophosphamide in rheumatoid arthritis. New England Journal of Medicine 283: 883–889 (1970).
Decker, J.L.: Apheresis and rheumatoid arthritis. Annals of Internal Medicine 98: 666–667 (1983).
Finkelstein, A.E.; Roisman, R.F.; Ladizesky, M.G. and Walz, D.T.. Auranofin and lysosomal enzymes. Journal of Rheumatology 9 (Suppl. 8): 46–53 (1982).
Furst, D.E.; Landow, E.M.; Dromgoole, S.H.; Blocka, K. and Paulus, H.E.: Pharmacokinetics of auranofin after single and multiple dosing. Clinical Pharmacology and Therapeutics 31: 227 (1982).
Gofton, J.P. and O’Brien, W.M.: Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 169–172 (1982).
Herrlinger, J.D.; Alsen, C.; Beress, R.; Hecker, V. and Weikert, W.: Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds. Journal of Rheumatology 9 (Suppl. 8): 81–89 (1982).
Heuer, M. and Morris, R.: Smith, Kline & French worldwide clinical experience with auranofin: A review (Excerpta Medica, Amsterdam 1983).
Hochberg, M.C.: Long-term double-blind study of auranofin and D-penicillamine in the treatment of rheumatoid arthritis. (In progress.) Personal communication (1984).
Iannuzzi, L.; Dawson, N.; Zein, N. and Kushner, I.: Does drug therapy slow radiographic deterioration in rheumatoid arthritis? New England Journal of Medicine 309: 1023–1028 (1983).
Jaffe, I.A.: Intra-articular dissociation of the rheumatoid factor. Journal of Laboratory and Clinical Medicine 60: 409–421 (1962).
Katz, W.A.; Alexander, S.; Bland, J.H.; Blechman, W.; Bluhm, G.B.; Bonebrake, R.A.; Falbo, A.; Greenwald, R.A.; Hartman, S.; Hobbs, T.; Indenbaum, S.; Lergier, J.E.; Lanier, B.G.; Lightfoot, R.W.; Phelps, P.; Sheon, R.P.; Torretti, D.; Wenger, M.E. and Wilske, K.: The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 173–178 (1982).
Lipsky, P.E.: Remission-inducing therapy in rheumatoid arthritis. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 40–49 (1983).
Luthra, H.S.; Dillon, A.M.; Bunch, T.W.; O’Duffy, J.D.; Conn, D.L. and O’Fallon, W.M.: Comparison of auranofin and D-penicillamine in the treatment of progressive rheumatoid arthritis. (In progress, 1984).
McCarty, D.J. and Carrera, G.F.: Intractable rheumatoid arthritis: Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. Journal of the American Medical Association 248: 1718–1723 (1982).
Menard, H.A.; Beaudet, F.; Davis, P.; Harth, M.; Percy, J.S.; Russell, A.S. and Thompson, J.M.: Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. Journal of Rheumatology 9 (Suppl. 8): 179–183 (1982).
Multicenter Trial Group: Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1: 275–280 (1983).
O’Brien, W.M.: Pharmacology of nonsteroidal anti-inflammatory drugs: Practical review for clinicians. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 32–39 (1983).
Page, F.: Treatment of lupus erythematosus with mepacrine. Lancet 2: 755–758 (1951).
Pinals, R.S.: Approaches to rheumatoid arthritis and osteoarthritis: An overview. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 2–9 (1983).
Pinals, R.S.; Masi, A.T.; Larson, R.A. and the Subcomittee for Criteria of Remission in Rheumatoid Arthritis of the American Association Diagnostic and Therapeutic Criteria Committee: Arthritis. Arthritis and Rheumatism 24: 1308–1315 (1981).
Rothermich, N.O.; Thomas, M.H.; Phillips, V.K. and Bergan, W.: Clinical trial of penicillamine in rheumatoid arthritis. Arthritis and Rheumatism 24: 1473–1478 (1981).
Rothermich, N.O.; Phillips, V.K.; Bergan, W. and Thomas, M.H.: Follow-up study of chrysotherapy. Arthritis and Rheumatism 22: 423 (1979).
Runge, L.A.: Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritis: Proceedings of a Symposium: A Reassessment of Plaquenil in the Treatment of Rheumatoid Arthritis. American Journal of Medicine (Suppl., Oct. 31): 52–56 (1983).
Rynes, R.I.: Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment. Proceedings of a Symposium: A Reassessment of Plaquenil in the Treatment of Rheumatoid Arthritis. American Journal of Medicine (Suppl., Jul. 18): 35–39 (1983).
Salmeron, G. and Lipsky, P.E.: Modulation of human immune responsiveness in vitro by auranofin. Journal of Rheumatology 9 (Suppl. 8): 25–31 (1982).
Schattenkirchner, M.; Kaik, B.; Mulier-Fassbender, H.; Rau, R. and Zeidler, H.: Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Journal of Rheumatology 9 (Suppl. 8): 184–189 (1982).
Schorn, D.: An oral gold formulation in RA. South African Medical Journal 62: 313–316 (1982).
Smith, P.R.; Brown, G.M.M. and Meyers, O.L.: An open comparative study of auranofin versus gold sodium thiomalate. Journal of Rheumatology 9 (Suppl. 8): 197–200 (1982).
Walz, D.T.; Di Martino, M.J. and Griswold, D.E.: Comparative pharmacology and biological effects of different gold compounds. Journal of Rheumatology 9 (Suppl. 8): 54–60 (1982a).
Walz, D.T.; Di Martino, M.J. and Griswold, D.E.: Mechanisms of action of auranofin: Effects of humoral immune response. Journal of Rheumatology 9 (Suppl. 8): 32–36 (1982b).
Ward, J.R.; Williams, H.J.; Egger, M.J.; Reading, J.C.; Boyce, E.; Altz-Smith, M.; Samuelson, C.O.; Willkens, R.F.; Solsky, M.A.; Hayes, S.P.; Blocka, K.L.; Weinstein, A.; Meenan, R.F.; Guttadauria, M.; Kaplan, S.B. and Kippel, J.: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 26: 1303–1315 (1983).
Weisman, M.H.; Hannifin, D.M.; Guerra Jr, J.; Resnik, C. and Rcsnick, D.: Analysis of auranofin as a rheumatoid remitting agent. Journal of Rheumatology 9 (Suppl. 8): 132–136 (1982).
Willkens, R.F.: Reappraisal of the use of methotrexate in rheumatic disease. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 19–25 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Duffy, J.D., Luthra, H.S. Current Status of Disease-Modifying Drugs in Progressive Rheumatoid Arthritis. Drugs 27, 373–377 (1984). https://doi.org/10.2165/00003495-198427050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198427050-00001